Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Uncover which travel rewards program is best suited for your needs. Make the most of your rewards and enhance your travel experience.
23,083 articlesAxsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Oklo edges toward its first commercial nuclear power with government negotiations and a European funding alliance, ex...
Analysts warn that social security faces insolvency by 2032, threatening to reduce guaranteed benefits for 70 million...
As Rocket Lab broadens beyond launches into aerospace and defense, a renewed thesis supports a potential growth path ...
A wave of borrowing among AI builders is reshaping how investors view growth. NVIDIA, Oracle, and SpaceX are tapping ...
Poet Technologies faces a pivotal year as AI-driven optical interconnects scale. This report analyzes catalysts, risk...
A looming funding cliff could shrink benefits for millions. This guide breaks down the numbers, the political dynamic...
CHLA pushes for an FHA pilot that would pay lenders directly for sub-$100K mortgages, arguing the move is needed to u...
NASA slows plans for Artemis II after engineers find a helium-flow issue in the upper stage, forcing a rollback to th...
As the space economy matures, investors face a clear choice between Redwire and Rocket Lab. This guide breaks down bu...